Momenta Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Momenta Pharmaceuticals Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Momenta Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Momenta Pharmaceuticals Inc.

Back to companies

Momenta Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Momenta Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4286011A2 Application Fcrn-antikörper und verfahren zur verwendung davon A61K2039/505; A61P1/04; A61P1/16; A61P11/00; A61P13/12; A61P17/00; A61P17/06; A61P17/14; A61P19/02; A61P19/08; A61P21/00; A61P21/04; A61P25/00; A61P27/16; A61P29/00; A61P3/02; A61P3/10; A61P3/14; A61P37/00; A61P37/04; A61P37/06; A61P5/40; A61P7/04; A61P7/06; A61P9/04; A61P9/10; C07K16/283; C07K2317/33; C07K2317/41; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 December 06, 2023
EP3484514B1 Grant Zusammensetzungen und verfahren im zusammenhang mit manipulierten fc-konstrukten C12N15/85; C12N5/0686; A61K2039/505; A61K39/395; A61P29/00; A61P37/00; A61P37/02; A61P37/06; A61P43/00; C07K16/00; C07K16/46; C07K16/468; C07K2317/524; C07K2317/526; C07K2317/53; C07K2317/60; C07K2317/94; C07K2319/30 December 06, 2023
RS64768B1 Grant Fcrn antibodies and methods of use thereof A61K2039/505; A61P1/04; A61P1/16; A61P11/00; A61P13/12; A61P17/00; A61P17/06; A61P17/14; A61P19/02; A61P19/08; A61P21/00; A61P21/04; A61P25/00; A61P27/16; A61P29/00; A61P3/02; A61P3/10; A61P3/14; A61P37/00; A61P37/04; A61P37/06; A61P5/40; A61P7/04; A61P7/06; A61P9/04; A61P9/10; C07K16/283; C07K2317/33; C07K2317/41; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 November 30, 2023
AU2022256389A1 Application Compositions and methods for treating pediatric myasthenia gravis A61K39/395; A61P21/00; A61P21/04; C07K16/283 November 30, 2023
EP4282487A2 Application Fcrn-antikörper und verfahren zur verwendung davon A61K2039/505; A61P1/04; A61P1/16; A61P11/00; A61P13/12; A61P15/06; A61P17/00; A61P17/06; A61P17/14; A61P19/00; A61P19/02; A61P21/00; A61P21/04; A61P25/00; A61P27/02; A61P27/16; A61P29/00; A61P3/10; A61P31/12; A61P31/14; A61P31/16; A61P31/18; A61P31/20; A61P37/00; A61P37/02; A61P37/06; A61P5/14; A61P7/00; A61P7/04; A61P7/06; A61P9/00; C07K16/28; C07K16/283; C07K2317/34; C07K2317/41; C07K2317/565; C07K2317/76; C07K2317/92 November 29, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer